Results 291 to 300 of about 1,439,975 (404)

Low-Density Lipoprotein Cholesterol Level, the Lower the Better? Analysis of Korean Patients in the Treat Stroke to Target Trial. [PDF]

J Stroke
Kwon H, Ryu JC, Cha JK, Sung SM, Song TJ, Lee KB, Kim EG, Kim YW, Heo JH, Park MS, Kang K, Lee BC, Hong KS, Bang OY, Kim J, Kim JS.   +15 more
europepmc   +1 more source

Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts.

, 1979
T L Innerarity, Robert E. Pitas, Robert W. Mahley   +2 more
openalex   +1 more source

CD36 is a receptor for oxidized low density lipoprotein.

Journal of Biological Chemistry, 1993
G. Endemann, L. Stanton, K. Madden, C. M. Bryant, R. T. White, A. Protter   +5 more
semanticscholar   +1 more source

The structure of apolipoprotein B100 from human low-density lipoprotein. [PDF]

Nature
Berndsen ZT, Cassidy CK.
europepmc   +1 more source

Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation

Circulation, 2013
A. Varbo, M. Benn, A. Tybjærg‐Hansen, B. Nordestgaard   +3 more
semanticscholar   +1 more source

The Impact of SNP Score on Low-Density Lipoprotein Cholesterol Concentration and Coronary Artery Disease. [PDF]

Int J Mol Sci
Čereškevičius D, Čiapienė I, Aldujeli A, Zabiela V, Lesauskaitė V, Zubielienė K, Raškevičius V, Žaliaduonytė D, Unikas R, Pranevičius R, Simanauskas I, Bakšytė G, Tamošiūnas A, Lukšienė D, Šakalytė G, Tatarūnas V.   +15 more
europepmc   +1 more source

Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries

Arthritis &Rheumatology, EarlyView.
Objective Our objective was to assess the incidence of major adverse cardiovascular events (MACEs) in patients with rheumatoid arthritis (RA) treated with JAK inhibitors (JAKi), tumor necrosis factor inhibitors (TNFi), or biologic disease‐modifying antirheumatic drugs with other modes of action (bDMARD‐OMA) in a multicountry, real‐world population ...
Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling, Denis Choquette, Catalin Codreanu, Daniela Di Giuseppe, Irini Flouri, Doreen Huschek, Kimme L. Hyrich, Florenzo Iannone, Tore K. Kvien, Burkhard F. Leeb, Dan Nordström, Lucia Otero‐Varela, Karel Pavelka, Manuel Pombo‐Suarez, Ana Rodrigues, Ziga Rotar, Prodromos Sidiropoulos, Sella A. Provan, Anja Strangfeld, Trokovic Nina, Jakub Zavada, Lianne Kearsley‐Fleet, Delphine S. Courvoisier, Axel Finckh, Kim Lauper   +28 more
wiley   +1 more source

An equation for calculating small dense low-density lipoprotein cholesterol. [PDF]

Lipids Health Dis
Han T, Piao Z, Yu Z, Xu W, Cui X.
europepmc   +1 more source

Gout and NLRP3 Inflammasome Biology

Arthritis &Rheumatology, EarlyView.
This review describes the three broad stages of acute inflammation in the context of gout: initiation, leucocyte mobilization, and self‐resolution. A typical case of a gout flare is presented. The role of the NLRP3 inflammasome in acute monosodium urate crystal–induced inflammation is reviewed in detail.
Raewyn Poulsen, Nicola Dalbeth
wiley   +1 more source

Fenofibrate Treatment Inhibits Very-Low-Density Lipoprotein Transport Vesicle Formation by Reducing Sar1b Protein Expression. [PDF]

Int J Mol Sci
Winterfeldt K, Tasin FR, Sekhar V, Siddiqi SA.   +3 more
europepmc   +1 more source